Profile | DEVELOPER

Logo	Name	Type	Year of Establishment	Industry Tag
	Cyagen	Industry Player	2005	Medical
Hi we’re Cyagen! Cyagen Biosciences, an AI-enabled CRO company specializing in custom genetically engineered animal and cell models for research.
	Merge Labs	Startup	2025
Hi we’re Merge Labs! Merge Labs, is exploring innovative approaches to enhance human-AI interaction, including the genetic modification of brain cells to improve implant compatibility.
	CorriXR Therapeutics	Startup	2022	Medical
Hi we’re CorriXR Therapeutics! CorriXR Therapeutics is on the clinical frontier of gene editing as a transformative pre-clinical stage biotechnology company with a ground-breaking in vivo gene editing therapeutic platform technology. CorriXR Therapeutics advances CRISPR/Cas gene editing technology to develop new genetic medicines directed against drug-resistant solid tumors.
	Anocca	Industry Player	2014	Medical
Hi we’re Anocca! Anocca was founded in 2014 to build biotechnologies, processes and infrastructure needed to decode T-cell immunity, with the ambition to build new forms of T-cell immunotherapies.
	Shattuck Labs	Startup	2016	Medical
Hi we’re Shattuck Labs! Shattuck Labs is a biotechnology company focused on developing potential treatments for autoimmune and inflammatory diseases. The company is advancing a potentially first-in-class antibody for inflammatory bowel disease (IBD) and other autoimmune conditions, leveraging its expertise in protein engineering
	Axelyf Inc	Startup	2022	Medical
Hi we’re Axelyf Inc! Axelyf, Inc., a biotechnology company developing next-generation lipid nanoparticle (LNP) delivery systems for RNA therapeutics.
	iNtRON Bio	Industry Player	1999	Medical
Hi we’re iNtRON Bio! iNtRON Bio, a KOSDAQ-listed company with a strong focus on R&D since its foundation, is advancing as a global biopharmaceutical innovator through the development of First-in-Class bio-drugs and clinical programs. The company has also filed two patents for its IMPA™ platform, which integrates CRISPR-Cas9 and recombination-based methods to engineer Pasteurella bacteriophages.
	Neoplants	Startup	2018	Synthetic Biology
Hi we’re Neoplants! Neoplants is a French synthetic biology startup that bioengineers houseplants—particularly pothos (Epipremnum aureum)—to purify indoor air by targeting volatile organic compounds (VOCs) like benzene and toluene. Their flagship product, Neo Px, combines genetically enhanced plants with a proprietary microbiome system, achieving up to 30 times greater air purification efficiency compared to traditional houseplants